Study Summary
This trial is testing whether a dietary supplement called citicoline will improve sleep and cognition in people with Alzheimer's disease. Citicoline has been shown to be well tolerated in previous studies.
Treatment Effectiveness
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: Baseline and 3 months
Trial Safety
Trial Design
2 Treatment Groups
Citicoline Supplement
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
20 Total Participants · 2 Treatment Groups
Primary Treatment: Citicoline supplement · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many participants has the research team recruited for this project?
"Affirmative. Clinicaltrials.gov indicates that this research trial, which was initially posted on July 27th 2022, is still actively seeking participants. The current goal is to enroll 20 individuals from two different medical facilities." - Anonymous Online Contributor
Are there any available spaces for participants in this research endeavor?
"Per the details available on clinicaltrials.gov, this research is currently enrolling participants and has been since its original posting date of July 27th 2022 - no updates have taken place in the interim." - Anonymous Online Contributor